Yahoo Web Search

Search results

1. • 

     The Best Products For Treating Psoriasis, According To Dermatologists

     HuffPost· 3 days ago

     Dr. Carolyn Stull, board-certified... Dermatology in New York City, described psoriasis as a chronic...

2. • 

     Tapinarof may mark Dermavant’s first atopic dermatitis approval

     Clinical Trials Arena via Yahoo Finance· 3 days ago

     Tapinarof is an aryl hydrocarbon receptor (AhR) receptor modulator that has been observed to have...

3. • 

     Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials

     FierceBiotech· 5 days ago

     Specifically, Alumis plans to use part of the IPO haul to advance the development of its lead asset,...

4. • Short Interest in UCB SA (OTCMKTS:UCBJY) Rises By 152.5%

     ETF DAILY NEWS· 21 hours ago

     UCB SA (OTCMKTS:UCBJY – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 15,400 shares, a growth of 152.5% from ...

5. • Sanibel Captiva Trust Company Inc. Takes Position in Amgen Inc. (NASDAQ:AMGN)

     ETF DAILY NEWS· 19 hours ago

     Sanibel Captiva Trust Company Inc. bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought ...

6. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 5 days ago

     Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment66.2% of participants treated ...

7. • 

     Roflumilast cream shows promise for long-term AD control By Investing.com

     Investing.com· 5 days ago

     (NASDAQ:ARQT), a commercial-stage biopharmaceutical company, announced new study results today for...

8. • Shell Asset Management Co. Sells 9,507 Shares of AbbVie Inc. (NYSE:ABBV)

     ETF DAILY NEWS· 5 days ago

     Shell Asset Management Co. cut its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 19.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities ...

9. • 

     OPINION: My patients can’t afford two crucial medications, and Big Pharma should be held accountable

     Montrose Daily Press· 7 days ago

     As a physician, I am encouraged and impressed with the work that Colorado’s Prescription Drug...

10. • My Skin Is Aging In Reverse (& I Attribute It To This At-Home Practice)

      MindBodyGreen· 7 days ago

      Most LED devices come with a hefty price tag, but this wand is only $99 (and even less with our exclusive discount code MINDBODYGREEN). Keep reading to learn why I'm convinced this is a must-have ...